Elizabeth Holmes fails to overturn her Theranos fraud conviction


Holmes was CEO throughout Theranos’ turbulent 15-year history, claimed her startup had developed a revolutionary medical device that could detect a multitude of diseases and conditions from a few drops of blood. But the technology never worked, and the claims were false. — AP

SAN FRANCISCO: Elizabeth Holmes, the disgraced founder of Theranos, will remain in prison after losing a bid on Feb 24 to overturn her fraud conviction, with a federal appeals court saying she hadn’t proved there were legal missteps during her trial for defrauding investors with false claims of what her blood-testing startup could achieve.

The three-judge panel in San Francisco also upheld the fraud conviction of Holmes’ former business partner and lover Ramesh "Sunny” Balwani – as well as a lower’s court order for the two to pay US$452mil (RM1.99bil) in restitution.

Holmes was CEO throughout Theranos’ turbulent 15-year history, claimed her startup had developed a revolutionary medical device that could detect a multitude of diseases and conditions from a few drops of blood. But the technology never worked, and the claims were false.

A 41-year-old mother of two small children, Holmes began serving her 11-year sentence in May 2023 at a federal prison in Texas. Her listed release date at the Federal Bureau of Prisons is currently March 19, 2032.

Balwani, 59, was sentenced to nearly 13 years in prison in California for his role in the scam and is set to be released in 2033.

The pair alleged in their appeal that legal errors were committed during their separate trials in 2022 when the court allowed some testimony, including that of a former Theranos employee, and improperly prohibited other testimony.

Judge Jacqueline Nguyen rejected the claims, writing in the 54-page ruling that they failed to prove any violations or major errors by the lower court.

Attorneys for Holmes and Balwani did not immediately respond to emails seeking comment by The Associated Press.

Holmes saw a meteoric rise in Silicon Valley that landed her on the covers of business magazines that hailed her as the next Steve Jobs and raised nearly US$1bil (RM4.42bil) in investments from software magnate Larry Ellison, media mogul Rupert Murdoch and the Walton family behind Walmart, and many others.

While wooing investors, Holmes leveraged a high-powered Theranos board that included former Defense Secretary James Mattis, who testified against her during her trial, and two former secretaries of state, Henry Kissinger and the late George Shultz, whose son, Alexander submitted a statement blasting Holmes for concocting a scheme that played Shultz "for the fool.”

The deception came to light in 2015 after a series of explosive articles in The Wall Street Journal and a regulatory audit of Theranos uncovered potentially dangerous flaws in the company’s technology, leading to its eventual collapse.

One of Silicon Valley’s biggest scandals, the pair's blood-testing hoax has been dissected in a book, an HBO documentary and an award-winning TV series. – AP

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

What's my age again? The tech behind Australia's social media ban
Amazon to invest over $35 billion in India by 2030 to expand operations, boost AI capabilities
Taiwan RedNote ban backfires, driving mainland Chinese app’s top download rise
Apple chip chief tells staff he’s not leaving 'anytime soon'
Japan’s cyber chief warns nation still behind on cybersecurity
World watches first teen social media ban kick off in Australia
Samsung SDI unit signs US battery deal worth over $1.36 billion for energy storage systems
Hinge CEO McLeod stepping down to lead Match Group-backed AI dating startup
Britons watch YouTube for 51 minutes a day, regulator Ofcom says
Samsung SDI unit signs $1.4 billion LFP battery deal for US customer

Others Also Read